• Home
  • Company
    • Our Vision
    • Our Team
    • Partners
  • Technology
  • Applications
    • Drug Safety
    • Drug efficacy
    • Our Services
      • DishTrial4LiverTox™
      • DishTrial4OncoEfficacy™
  • Work With Us
  • News
  • Publications
  • Home
  • Company
    • Our Vision
    • Our Team
    • Partners
  • Technology
  • Applications
    • Drug Safety
    • Drug efficacy
    • Our Services
      • DishTrial4LiverTox™
      • DishTrial4OncoEfficacy™
  • Work With Us
  • News
  • Publications

Jour : 11 septembre 2026

A serum-derived 3D tumor model platform for personalized prediction and monitoring of chemotherapeutic response in pancreatic ductal adenocarcinoma

sing individual-centric model to detect immune-mediated idiosyncratic drug-induced liver injury at preclinical stage

AI-enhanced clinical trial-in-a-dish platform for improved DILI risk classification and mechanistic insights into hepatotoxicity

sing individual-centric model to detect immune-mediated idiosyncratic drug-induced liver injury at preclinical stage

A new in vitro rat liver platform capturing biological diversity for drug-induced liver injury assessment and reduction of animal use in drug discovery and development

sing individual-centric model to detect immune-mediated idiosyncratic drug-induced liver injury at preclinical stage

PredictCan_Logo_01
  • Privacy Policy
  • Legal Notice
  • Privacy Policy
  • Legal Notice

Follow us

Linkedin Twitter

© 2026 - predictcan | Tous Droits Réservés

By JCD Groupe

  • Home
  • Company
    • Our Vision
    • Our Team
    • Partners
  • Technology
  • Applications
    • Drug Safety
    • Drug efficacy
    • Our Services
      • DishTrial4LiverTox™
      • DishTrial4OncoEfficacy™
  • Work With Us
  • News
  • Publications
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.